Table 2.
Outcomes | Unadjusted |
Adjusted* |
|||
---|---|---|---|---|---|
Estimate (95% CI) | P Value | Estimate (95% CI) | P Value | % | |
Primary outcome—subdistribution hazard ratio | |||||
Rate of discharge† | 0.6 (0.6–0.7) | <0.001 | 0.8 (0.7–0.9) | 0.001 | — |
Secondary outcomes—risk ratios | |||||
In-hospital mortality | 3.5 (2.3–5.3) | <0.001 | 1.2 (0.9–1.6) | 0.3 | Localized: 8 |
Dispersed: 10 | |||||
Discharge to home | 0.9 (0.8–0.9) | <0.001 | 0.95 (0.91–0.99) | 0.03 | Localized: 77 |
Dispersed: 73 | |||||
Discharge to skilled nursing facilities | 1.7 (1.3–2.2) | <0.001 | 1.5 (1.1–2.0) | 0.01 | Localized: 11 |
Dispersed: 16 | |||||
90-d hospital readmissions | 1.0 (0.8–1.1) | 0.7 | 1.0 (0.8–1.1) | 0.6 | Localized: 33 |
Dispersed: 31 |
Definition of abbreviation: CI = confidence interval.
Models were adjusted for: age, gender, race, ethnicity, insurance type, Elixhauser comorbidity scores, the Centers for Medicare and Medicaid Services four-level severity risk adjustment (based on admitting diagnosis, demographics, and comorbidities), admission diagnosis category (from International Classification of Diseases-9 and -10 codes), daily mean number of pulmonary service patients by hospital during the hospitalization, code status (full vs. any limitation on life-sustaining therapies), hospital admission source, intensive care unit as the ward admission source, season, and the patient’s hospital.
Estimated using a Fine and Gray competing risks model to account for the competing risk of death.